Jun 2026 (Q2 FY26) — Aug 4, 2026
TETRA Technologies Q2 FY26 — Strong Financials and Strategic Milestones
Read the full callTETRA Technologies earnings: last reported Tue, 4 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 186 | +6.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 10.8 | −2.4 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 10.2 | −9.4% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
1Y: $7.04 on 14 Oct 2025 → $5.31. High $12.32 (3 Feb 2026), low $5.31 (15 Oct 2026).
Overview
Call summaries
TETRA Technologies Q2 FY26 — Strong Financials and Strategic Milestones
Read the full callEvery analysed call
Financials
Net profit, year on year: −9% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 142 | 135 | 157 | 174 | 153 | 147 | 156 | 186 |
| Expenses | 107 | 103 | 114 | 126 | 117 | 118 | 118 | 140 |
| Operating profit | 12 | 8 | 19 | 23 | 11 | 3 | 13 | 20 |
| Operating margin | 8.4% | 6.0% | 11.9% | 13.2% | 7.3% | 1.7% | 8.2% | 10.8% |
| Interest | 5 | — | 5 | 4 | 4 | — | 3 | 3 |
| Profit before tax | 8 | 7 | 5 | 19 | 8 | -6 | 12 | 16 |
| Tax rate | 62.6% | −1283.0% | 20.4% | 41.8% | 48.8% | −149.8% | 28.2% | 35.4% |
| Net profit | -3 | 103 | 4 | 11 | 4 | -16 | 8 | 10 |
| EPS ($ per share) | -0.02 | — | 0.03 | 0.08 | 0.03 | — | 0.06 | 0.07 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | -218 | -363 | -414 | -310 | -302 | -277 | -168 | -165 |
| Total liabilities | 1,073 | 1,109 | 1,062 | 300 | 328 | 332 | 352 | 393 |
| Fixed assets | 854 | 116 | 97 | 89 | 102 | 108 | 142 | 194 |
| Total assets | 1,386 | 1,272 | 1,133 | 398 | 434 | 479 | 605 | 676 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 47 | 90 | 77 | 5 | 19 | 70 | 37 | 100 |
| Cash from investing | -189 | -106 | 6 | -5 | -37 | -27 | -59 | -61 |
| Cash from financing | 155 | -6 | -18 | -50 | 0 | -5 | 9 | -5 |
| Net cash flow | 14 | -22 | 66 | -52 | -18 | 39 | -15 | 35 |
| Capital expenditure | -142 | -108 | -29 | -21 | -40 | -38 | -61 | -81 |
| Free cash flow | -95 | -18 | 48 | -16 | -21 | 32 | -24 | 20 |
84 filings between Nov 10, 2025 and Oct 4, 2026.
Purchases
$281.9K
2 purchases by 2 insiders
Sales
$689.7K
4 sales by 2 insiders
50% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 1 other.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Murphy Brady M | — | $536.7K | Jul 2, 2026 |
| Hallead Kurt | $216.9K | — | Jun 9, 2026 |
| Boston Shoemake Alicia r | — | $153.0K | Nov 10, 2025 |
| John Angela D | $65.0K | — | Sep 2, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 4, 2026 | Moeller Timothy C Sr. Vice President | Option exercise | 25,000 | $0 |
| Oct 4, 2026 | Moeller Timothy C Sr. Vice President | Tax withheld | 9,838 | $59.0K |
| Sep 29, 2026 | Kokenes Kathrine VP & Chief Accounting Officer | Tax withheld | 3,691 | $21.4K |
| Sep 29, 2026 | Kokenes Kathrine VP & Chief Accounting Officer | Option exercise | 9,881 | $0 |
| Sep 2, 2026 | John Angela D Director | Purchase | 10,000 | $65.0K |
| Aug 25, 2026 | Boston Shoemake Alicia r Sr. VP and General Counsel | Tax withheld | 3,174 | $21.5K |
| Aug 25, 2026 | McNiven Roy Sr. Vice President | Option exercise | 13,612 | $0 |
| Aug 25, 2026 | Murphy Brady M President & CEO | Option exercise | 58,282 | $0 |
| Aug 25, 2026 | Moeller Timothy C Sr. Vice President | Tax withheld | 5,357 | $36.3K |
| Aug 25, 2026 | Murphy Brady M President & CEO | Option exercise | 60,496 | $0 |
| Aug 25, 2026 | Murphy Brady M President & CEO | Tax withheld | 22,934 | $155.3K |
| Aug 25, 2026 | McNiven Roy Sr. Vice President | Option exercise | 13,599 | $0 |
| Aug 25, 2026 | SANDERSON MATTHEW Executive Vice President & CFO | Option exercise | 15,124 | $0 |
| Aug 25, 2026 | McNiven Roy Sr. Vice President | Tax withheld | 5,357 | $36.3K |
| Aug 25, 2026 | SANDERSON MATTHEW Executive Vice President & CFO | Option exercise | 14,570 | $0 |
| Aug 25, 2026 | SANDERSON MATTHEW Executive Vice President & CFO | Tax withheld | 5,952 | $40.3K |
| Aug 25, 2026 | Murphy Brady M President & CEO | Tax withheld | 23,806 | $161.2K |
| Aug 25, 2026 | McNiven Roy Sr. Vice President | Tax withheld | 5,352 | $36.2K |
| Aug 25, 2026 | Boston Shoemake Alicia r Sr. VP and General Counsel | Option exercise | 9,713 | $0 |
| Aug 25, 2026 | SANDERSON MATTHEW Executive Vice President & CFO | Tax withheld | 5,734 | $38.8K |
| Aug 25, 2026 | Moeller Timothy C Sr. Vice President | Option exercise | 13,612 | $0 |
| Aug 25, 2026 | Boston Shoemake Alicia r Sr. VP and General Counsel | Tax withheld | 3,823 | $25.9K |
| Aug 25, 2026 | Moeller Timothy C Sr. Vice President | Option exercise | 13,599 | $0 |
| Aug 25, 2026 | Boston Shoemake Alicia r Sr. VP and General Counsel | Option exercise | 8,066 | $0 |
| Aug 25, 2026 | Moeller Timothy C Sr. Vice President | Tax withheld | 5,352 | $36.2K |
| Jul 2, 2026 | Murphy Brady M President & CEO | Sale 10b5-1 plan | 61 | $610 |
| Jul 1, 2026 | Murphy Brady M President & CEO | Sale 10b5-1 plan | 50,000 | $536.1K |
| Jun 12, 2026 | John Angela D Director | Option exercise | 37,723 | $0 |
| Jun 12, 2026 | McGee Sharon D. Booth Director | Option exercise | 37,723 | $0 |
| Jun 12, 2026 | Garcia Christian A Director | Option exercise | 37,723 | $0 |
| Jun 12, 2026 | BATES THOMAS R JR Director | Option exercise | 37,723 | $0 |
| Jun 12, 2026 | GLICK JOHN F Director | Option exercise | 51,441 | $0 |
| Jun 9, 2026 | Hallead Kurt VP-Treasurer & IR | Purchase | 22,000 | $216.9K |
| Mar 14, 2026 | Moeller Timothy C SVP - Supply Chain & Chemicals | Option exercise | 82,593 | $0 |
| Mar 14, 2026 | Murphy Brady M President & CEO | Tax withheld | 157,401 | $1.29M |
| Mar 14, 2026 | Murphy Brady M President & CEO | Option exercise | 371,666 | $0 |
| Mar 14, 2026 | SANDERSON MATTHEW Executive Vice President | Tax withheld | 38,157 | $313.7K |
| Mar 14, 2026 | SANDERSON MATTHEW Executive Vice President | Option exercise | 86,034 | $0 |
| Mar 14, 2026 | SERRANO ELIJIO V Sr. Vice President & CFO | Option exercise | 137,654 | $0 |
| Mar 14, 2026 | Boston Shoemake Alicia r Sr. VP and General Counsel | Tax withheld | 13,001 | $106.9K |
| Mar 14, 2026 | Moeller Timothy C SVP - Supply Chain & Chemicals | Tax withheld | 37,043 | $304.5K |
| Mar 14, 2026 | Boston Shoemake Alicia r Sr. VP and General Counsel | Option exercise | 33,037 | $0 |
| Mar 14, 2026 | SERRANO ELIJIO V Sr. Vice President & CFO | Tax withheld | 54,167 | $445.3K |
| Mar 11, 2026 | McNiven Roy Sr. Vice President | Other | 50,000 | $0 |
| Feb 28, 2026 | Boston Shoemake Alicia r Sr. VP and General Counsel | Tax withheld | 7,645 | $66.2K |
| Feb 28, 2026 | Boston Shoemake Alicia r Sr. VP and General Counsel | Option exercise | 19,427 | $0 |
| Feb 28, 2026 | Moeller Timothy C SVP - Supply Chain & Chemicals | Tax withheld | 12,199 | $105.6K |
| Feb 28, 2026 | Moeller Timothy C SVP - Supply Chain & Chemicals | Option exercise | 27,198 | $0 |
| Feb 28, 2026 | Murphy Brady M President & CEO | Tax withheld | 49,365 | $427.5K |
| Feb 28, 2026 | Murphy Brady M President & CEO | Option exercise | 116,564 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow TETRA TECHNOLOGIES INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading